These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Abbott agrees to expand access to Kaletra/Aluvia. AIDS Patient Care STDS; 2007 May; 21(5):366. PubMed ID: 17518529 [No Abstract] [Full Text] [Related]
3. Kaletra (ABT-378/r) approved. James JS AIDS Treat News; 2000 Sep; (351):2-3. PubMed ID: 12173550 [TBL] [Abstract][Full Text] [Related]
4. Access to drugs: the case of Abbott in Thailand. Cawthorne P; Ford N; Wilson D; Kijtiwatchakul K; Purahong V; Tianudom N; Nacapew S Lancet Infect Dis; 2007 Jun; 7(6):373-4. PubMed ID: 17521589 [No Abstract] [Full Text] [Related]
5. [When Doctors Without Borders writes to Miles White, chairman of Abbott Laboratories]. Nau JY Rev Med Suisse; 2006 Mar; 2(59):882. PubMed ID: 16646375 [No Abstract] [Full Text] [Related]
6. Aluvia tablet approved in 19 African countries. AIDS Patient Care STDS; 2007 Aug; 21(8):604-5. PubMed ID: 17902244 [No Abstract] [Full Text] [Related]
15. Improving access to second-line antiretrovirals. The Lancet Lancet; 2007 Apr; 369(9570):1320. PubMed ID: 17448798 [No Abstract] [Full Text] [Related]
16. FDA notifications. Abbott sends out provider letter about Kaletra for kids. AIDS Alert; 2007 Oct; 22(10):118. PubMed ID: 18416010 [No Abstract] [Full Text] [Related]
17. Drug pricing. AHF sues Abbott over drug price increase. AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045981 [No Abstract] [Full Text] [Related]